Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» M&A
M&A
Could Gilead, Amgen and AbbVie follow Bristol-Myers into megadeal territory?
Fierce Pharma
Sat, 01/5/19 - 01:34 pm
M&A
Bristol-Myers Squibb
Celgene
Gilead Sciences
AbbVie
Amgen
Celgene executives whipped up new, lucrative severance plans ahead of Bristol-Myers megadeal
Fierce Pharma
Sat, 01/5/19 - 12:12 am
Bristol-Myers Squibb
Celgene
M&A
severance
executive pay
The BMS-Celgene merger’s Achilles heel? An earlier-than-expected Revlimid patent loss
Fierce Pharma
Fri, 01/4/19 - 11:59 pm
Bristol-Myers Squibb
Celgene
M&A
Revlimid
patents
Should Celgene Investors Take Bristol's Money and Run?
Motley Fool
Fri, 01/4/19 - 10:01 am
Celgene
Bristol-Myers Squibb
M&A
Here’s What Bristol-Myers Squibb Will Look Like After Acquiring Celgene
Yahoo/Motley Fool
Fri, 01/4/19 - 09:14 am
M&A
Celgene
Bristol-Myers Squibb
Bristol-Myers Squibb And Celgene's Big Winner? Los Angeles Billionaire Patrick Soon-Shiong
Forbes
Thu, 01/3/19 - 11:47 pm
Patrick Soon-Shiong
Bristol-Myers Squibb
Celgene
M&A
BMS deal weighs on Celgene partners
BioCentury
Thu, 01/3/19 - 11:45 pm
M&A
Celgene
Bristol-Myers Squibb
Acceleron
BeiGene
Bristol-Myers to buy Celgene in industry-shaking $74B deal
Biopharma Dive
Thu, 01/3/19 - 09:50 am
M&A
Bristol-Myers Squibb
Celgene
immuno-oncology
Novartis (NVS) Benefits From New Drugs & Key Acquisitions
Yahoo/Zacks.com
Mon, 12/31/18 - 12:13 pm
Novartis
M&A
Boston Scientific acquires Millipede for $325m
Mass Device
Thu, 12/27/18 - 10:15 pm
Boston Scientific
devices
Millipede
M&A
Here are 5 medtech industry trends you need to know
Mass Device
Fri, 12/21/18 - 11:54 am
devices
M&A
grants
academia
regulatory
intellectual property
Rite Aid's PBM Suddenly Looks More Attractive
Forbes
Fri, 12/21/18 - 10:17 am
Rite Aid
PBMs
M&A
EnvisionRx
Medicare
Novartis seeks to acquire French CAR-T contract manufacturer
Biopharma Dive
Thu, 12/20/18 - 11:43 pm
Novartis
M&A
France
CellforCure
CMO
Kymriah
CAR-T
Merck KGaA hands off its CAR-T R&D operations to Intrexon in $175M deal
Endpoints
Thu, 12/20/18 - 11:50 am
Merck KGaA
CAR-T
Intrexion
M&A
Novartis unit Alcon picks up Tear Film Innovations
Mass Device
Thu, 12/20/18 - 11:48 am
Novartis
Alcon
M&A
eye health
Tear Film Innovations
devices
Long-awaited M&A boom will hit biopharma in 2019 despite persistent worries, prognosticators predict
Fierce Pharma
Thu, 12/20/18 - 12:24 am
M&A
Cigna-Express Scripts Merger A Done Deal By Thursday
Forbes
Thu, 12/20/18 - 12:17 am
Cigna
Express Scripts
PBMs
M&A
Pfizer and GSK Spin off Consumer Health Divisions Into a New Joint Venture
BioSpace
Wed, 12/19/18 - 11:46 am
Pfizer
GSK
M&A
spinoffs
consumer health
Clovis dips as Tesaro reveals more details of its acquisition
Biopharma Dive
Wed, 12/19/18 - 12:33 am
Clovis Oncology
Tesaro
M&A
Tesaro execs split $304M windfall from $5.1B GlaxoSmithKline buyout
Endpoints
Mon, 12/17/18 - 09:14 am
Tesaro
executive pay
M&A
GSK
Pages
« first
‹ previous
…
76
77
78
79
80
81
82
83
84
…
next ›
last »